What causes syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children with meningoencephalitis and raised intracranial pressure?

SIADH in Children with Meningoencephalitis and Raised Intracranial Pressure

Pathophysiologic Mechanism

Raised intracranial pressure (ICP) directly triggers inappropriate ADH release through mechanical compression of hypothalamic nuclei (particularly the paraventricular and supraoptic nuclei), independent of plasma osmolality. 1

Direct Mechanical Pathway

• Elevated ICP exerts physical pressure on ADH-secreting hypothalamic structures, causing non-osmotic ADH release even when plasma osmolality is low or normal 1
• This mechanical pressure model explains ADH secretion that traditional osmolality-based models cannot account for 1
• Children with tuberculous meningitis and laboratory evidence of SIADH demonstrate significantly higher ICP (median 22.5 mmHg) compared to those without SIADH (median 16.2 mmHg; P = 0.027) 2

Compensatory Hemodynamic Response

• Plasma ADH may be secreted as a compensatory response to raised ICP in an effort to raise mean arterial pressure (MAP) and maintain cerebral perfusion pressure 2
• A moderate correlation exists between MAP and plasma AVP (r = 0.62; P = 0.0019) in children with meningitis and raised ICP 2
• In this setting, excess fluid is inappropriately retained, leading to hyponatremia and hypo-osmolality 2

Clinical Context in Meningoencephalitis

Incidence and Severity Correlation

• SIADH occurs in 36.7% of children with acute bacterial meningitis on admission, with 12.5% still affected on day 3 3
• In tuberculous meningitis, biochemical evidence of SIADH is documented in 71% of children 4
• SIADH correlates significantly with severe meningeal inflammation (p < 0.001) 3
• The incidence is highest with Streptococcus pneumoniae (75%), followed by Haemophilus influenzae (57.1%) 3

Age-Related Vulnerability

• Children who develop SIADH in tuberculous meningitis are significantly older (median 34 months) than those who do not (median 10 months; P < 0.007) 4
• In enteroviral meningitis, the largest age group affected by SIADH is 1 to 5 years 5

Critical Distinction: SIADH vs Cerebral Salt Wasting

Volume status is the pivotal diagnostic feature separating SIADH from cerebral salt wasting (CSW): SIADH presents with euvolemia or mild hypervolemia, whereas CSW presents with clinical hypovolemia (reduced skin turgor, dry mucous membranes, orthostatic hypotension, tachycardia, low central venous pressure, negative fluid balance, weight loss) 6

• This distinction is critical because misdiagnosing CSW as SIADH and applying fluid restriction can precipitate cardiovascular collapse, worsen cerebral perfusion, and dramatically raise the risk of vasospasm and infarction in neurocritical patients 6
• When serum sodium falls below 131 mmol/L, the work-up should include measurement of serum and urine osmolarity, serum uric acid, together with meticulous fluid-balance monitoring and physical examination for volume status 6
• Routine measurement of ADH or natriuretic peptide levels is not recommended for differentiating CSW from SIADH because results are inconsistent and do not reliably aid diagnosis 6

Clinical Outcomes and Mortality

• Mortality is significantly higher (p < 0.001) in children with meningitis and SIADH, with all deaths occurring during the first 72 hours 3
• In tuberculous meningitis, 5 of 17 patients with SIADH died, compared to none without SIADH 4
• Untreated SIADH-related hyponatremia in neurocritical patients is associated with severe cerebral edema, altered mental status, and increased mortality 6

Management Principles

Fluid Management Strategy

• In meningoencephalitis with raised ICP, fluid restriction is the cornerstone of SIADH management 7
• Fluid restriction alone will result in correction of serum electrolyte composition in patients with SIADH 7
• However, fluid restriction must be avoided in subarachnoid hemorrhage patients with hyponatremia, as it significantly increases the incidence of cerebral infarction 6

Iatrogenic Risk Factor

• In tuberculous meningitis, patients who developed SIADH after hospitalization received significantly less fluid (median 58 ml/kg/day) before developing SIADH compared to those who did not develop SIADH (median 107 ml/kg/day; P = 0.035) 4
• This suggests that judicious fluid administration may help prevent SIADH development 4

Sodium Correction Safety

• Serum sodium should not be increased by more than 10 mmol/L per day to minimize the risk of osmotic demyelination syndrome 86
• Hypertonic saline should be used only in severely symptomatic patients 7
• Slower correction rates are particularly crucial for patients with malnutrition, chronic alcoholism, liver disease, or concurrent electrolyte abnormalities 8

Adjunctive Therapies Not Recommended

• Routine adjuvant therapy with mannitol, acetaminophen, antiepileptic drugs, or hypertonic saline is not recommended in bacterial meningitis 9
• Hypothermia and glycerol are contraindicated in bacterial meningitis 9
• Use of intracranial pressure/cerebral perfusion pressure monitoring and treatment can be life-saving in selected patients but cannot be recommended as routine management because solid evidence is lacking and harm may occur 9